Natera, Inc. is 6.4x more valuable than Caris Life Sciences, Inc. by market capitalization ($30.83 B vs $4.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CAI | NTRA |
|---|---|---|
| Market cap | $4.85 B | $30.83 B |
| US-listed rank | #1404 | #451 |
| Revenue (latest FY) | $812.03M | $2.31B |
| Net income (latest FY) | -$68.09M | -$208.16M |
| Net margin | -8.4% | -9.0% |
| SEC filings | 102 | 1,695 |
Natera, Inc. is 6.4x more valuable than Caris Life Sciences, Inc. by market capitalization ($30.83 B vs $4.85 B).
In their latest fiscal years, Caris Life Sciences, Inc. reported $812.03M in revenue while Natera, Inc. reported $2.31B.
Full pages: Caris Life Sciences, Inc. and Natera, Inc., or browse the full rankings.